| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 17.447 | 36.797 | 17.775 |
| Total Income - EUR | - | - | - | - | - | - | - | 18.360 | 73.588 | 42.888 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 10.031 | 65.566 | 40.405 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 8.328 | 8.022 | 2.483 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 8.328 | 6.738 | 1.428 |
| Employees | - | - | - | - | - | - | - | 1 | 3 | 2 |
Check the financial reports for the company - Ureopmic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 12 | 0 | 2.031 |
| Current Assets | - | - | - | - | - | - | - | 9.381 | 19.757 | 21.630 |
| Inventories | - | - | - | - | - | - | - | 1.671 | 11.717 | 16.592 |
| Receivables | - | - | - | - | - | - | - | 913 | 0 | 1.416 |
| Cash | - | - | - | - | - | - | - | 6.797 | 8.040 | 3.623 |
| Shareholders Funds | - | - | - | - | - | - | - | 8.369 | 15.082 | 16.425 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.024 | 4.676 | 7.236 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Ureopmic S.r.l.